Semaglutide 1 mg (Weekly injections X 4) Gallery
$$MultiPurposeText$$
See examples of our Semaglutide 1 mg (Weekly injections X 4) work and results.
What Our Clients Say
$$MultiPurposeText$$
Read testimonials from our satisfied customers
Great experience with doctor.
I got Great results with weight loss.
Reception was courteou...more
...more
Frequently Asked Questions
Get answers to common questions about Semaglutide 1 mg (Weekly injections X 4).
Candidates typically have BMI ≥27 with weight-related conditions or BMI ≥30; a clinical evaluation, medication review, and pregnancy screening are required. Not recommended for those with certain endocrine or gastrointestinal contraindications.
Many patients notice reduced appetite and smaller portions within one to two weeks, and measurable weight change by three to four weeks. This four-week protocol offers an early milestone, while optimal results often need continued therapy and lifestyle changes.
Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These are usually mild to moderate and transient. We provide dosing guidance and symptom management; report severe or persistent symptoms to our clinic immediately.
Semaglutide 1 mg is given as a once-weekly subcutaneous injection. Patients receive in-clinic dosing or training for self-injection, with scheduled follow-ups, weight checks, and lab monitoring to ensure safety and assess response during the four-week course.
Semaglutide pairs well with dietary adjustments, exercise, and behavioral therapy. Combining it with other medications or supplements requires clinician review due to interaction risks; our team will evaluate and coordinate a safe, integrated plan.
Semaglutide is not recommended during pregnancy or breastfeeding. Women of childbearing potential should use effective contraception during treatment and discuss plans with our team; discontinue therapy if pregnancy occurs and seek clinical guidance.